Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Lymphoma, Non-Hodgkin 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma 2Breast Neoplasms 2Rhabdomyosarcoma 1Retinoblastoma 1Recurrence 1Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Multiple Myeloma 1Lymphoma, AIDS-Related 1Leukemia, Myeloid, Accelerated Phase 1Leukemia 1Infiltrating Bladder Urothelial Carcinoma 1Hodgkin Disease 1HER2-positive Breast Cancer 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms, Male 1Blast Crisis 1Amyloidosis 1Adenocarcinoma, Bronchiolo-Alveolar 1Adenocarcinoma of Lung 1

Interventions

Methotrexate 4Cyclophosphamide 4ponatinib 3merphos 2Vincristine 2Tacrolimus 2Rituximab 2Mycophenolic Acid 2Cytarabine 2Cyclosporine 2CT-P10 2venetoclax 1prednylidene 1pegfilgrastim 1letermovir 1fludarabine phosphate 1dexamethasone acetate 1dexamethasone 21-phosphate 1deltacortene 1bosutinib 1blinatumomab 1auricularum 1Whole-Body Irradiation 1Vorinostat 1Valganciclovir 1Therapeutics 1Sirolimus 1Prednisone 1Polymerase Chain Reaction 1Peripheral Blood Stem Cell Transplantation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Leukemia, Myeloid, Accelerated Phase × pegfilgrastim × Clear all
NCT03147612 2026-02-17

Low-Intensity Chemotherapy, Ponatinib and Blinatumomab in Treating Patients With Philadelphia Chromosome-Positive and/or BCR-ABL Positive Acute Lymphoblastic Leukemia

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
22 enrolled
LymphoidOther hematologic neoplasm

Blast Crisis, Leukemia, Myeloid, Accelerated Phase, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡